The Drugs Panel is a specialized toxicology screening designed to detect a wide range of substances that pose significant health and legal risks. This panel is a critical tool used in medical, forensic, and workplace contexts to identify recent substance use and support public safety. By providing reliable and accurate results, the screening helps guide treatment plans, legal actions, and rehabilitation efforts, ensuring a safe and supportive environment for individuals and organizations alike.

The screening identifies various commonly misused substances, including stimulants, depressants, hallucinogens, and opioids, each of which has distinct physiological impacts on the body. Using advanced detection methods, the panel ensures high accuracy in identifying these substances in biological samples. Whether used for routine workplace safety, clinical assessment, or forensic investigation, the Drugs Panel offers the essential data needed to address substance abuse and promote long-term health and safety.